Corteva price target raised to $78 from $72 at RBC Capital

RBC Capital analyst Arun Viswanathan raised the firm’s price target on Corteva to $78 from $72 and keeps an Outperform rating on the shares after its smaller than expected Q3 earnings loss. The company is well positioned to benefit from macro and company specific self-help action despite market driven cost inflation, the analyst tells investors in a research note. Viswanathan adds that he is positive on the ag market and Corteva given the company’s strong visibility and its "somewhat recession proof nature".